|
|
|
|
|||||
|
|
|
New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 12 Best Dividend Stocks with Yields Above 4%.
Bristol-Myers Squibb Company (NYSE:BMY), headquartered in New Jersey, is a global pharmaceutical leader developing prescription drugs across areas such as oncology, hematology, cardiology, immunology, and neuroscience.
The company’s recent strategy emphasizes expanding its “Growth Portfolio” through new product launches, global market expansion, and acquisitions via strategic partnerships. A key challenge is offsetting revenue declines from older “Legacy Portfolio” drugs as patents expire and competition intensifies. Bristol-Myers Squibb Company (NYSE:BMY) prioritizes investment in research and development, forming strategic collaborations, and navigating global regulatory and pricing pressures.
Looking ahead, investors can expect strong sales from Cobenfy, a new schizophrenia treatment approved by the FDA last September, with projected revenues of $2.6 billion by 2030. For 2025, Bristol-Myers Squibb Company (NYSE:BMY) anticipates earnings between $6.35 and $6.65 per share, well above the $2.48 annualized dividend, indicating a solid capacity to maintain and potentially grow its high-yield dividend. With a robust lineup of new products to counteract upcoming patent expirations, the company’s dividend growth appears sustainable for at least the next decade.
Bristol-Myers Squibb Company (NYSE:BMY) has already increased its dividends for 16 consecutive years, which makes it one of the best dividend stocks. The company pays a quarterly dividend of $0.62 per share and has a dividend yield of 5.64%, as of October 12.
While we acknowledge the potential of BMY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 12 Most Promising Dividend Stocks According to Wall Street Analysts and Top 15 Dividend Growth Stocks for Long-Term Investors
Disclosure: None.
| Oct-13 | |
| Oct-13 | |
| Oct-13 | |
| Oct-13 | |
| Oct-13 | |
| Oct-13 | |
| Oct-11 | |
| Oct-10 | |
| Oct-10 | |
| Oct-10 | |
| Oct-10 | |
| Oct-10 | |
| Oct-10 | |
| Oct-10 | |
| Oct-08 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite